Form D · Pharmaceuticals
X-Rx, Inc.
Waltham, MA · CIK 0001565926
Offering snapshot reported Jan 4, 2013 · SEC filing
- Reported sold
- $8.5M Offering amount: $12M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 21, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 4, 2013 | Initial | $8,500,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-189565
Source: Form D, filed Jan 4, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lee Babiss | Executive |
| Daniel G. Darazsdi | Director |
| B. Judd Hartman | Director |
| Charles H. Munn, Jr. | Director |
| William J. Sharbaugh | Director |
| Jeffrey Troderman | Executive |
| Richard W. Wagner | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
100 Beaver Street Suite 101
Waltham, MA, 02453
Waltham, MA, 02453